HPTN 082
Status:Completed
Phase:Demo Project
Principal Investigator(s):
Objective:To assess the proportion and characteristics of young HIV-uninfected women who initiate versus do not initiate PrEP at enrollment; to assess the proportion of young women who continue and remain adherent to PrEP at Weeks 13 and 26, based on tenofovir (TFV) levels in plasma and/or dried blood spots (DBS).
Prevention Option(s):PrEP
Study Design:
Arms and Assigned Interventions
Description
Mode of Delivery
ARMs
Official Code:
NCT02732730
Trial Sponsors:
DAIDS, HPTN, NIAID, NIMH, Wits RHI
Start Date
End Date
June 1, 2016
August 1, 2018
Enrollment:600
Age range:
16 Years ↔
25 Years
Population:Cisgender Women